These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 34077781)
1. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer. Li F; Mao C; Yeh S; Sun Y; Xin J; Shi Q; Ming X Int J Pharm; 2021 Jul; 604():120760. PubMed ID: 34077781 [TBL] [Abstract][Full Text] [Related]
2. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer. Li F; Mao C; Yeh S; Xin J; Wang P; Shi Q; Ming X Int J Pharm; 2022 Sep; 625():122076. PubMed ID: 35931394 [TBL] [Abstract][Full Text] [Related]
3. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer. Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983 [TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903 [TBL] [Abstract][Full Text] [Related]
6. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging. Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859 [TBL] [Abstract][Full Text] [Related]
7. HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer. Takahashi K; Taki S; Yasui H; Nishinaga Y; Isobe Y; Matsui T; Shimizu M; Koike C; Sato K Cancer Med; 2021 Dec; 10(24):8808-8819. PubMed ID: 34729945 [TBL] [Abstract][Full Text] [Related]
8. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate. Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000 [TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755 [TBL] [Abstract][Full Text] [Related]
10. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer. Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134 [TBL] [Abstract][Full Text] [Related]
11. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265 [TBL] [Abstract][Full Text] [Related]
14. Near infrared photoimmunotherapy with an anti-mesothelin antibody. Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775 [TBL] [Abstract][Full Text] [Related]
15. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen. Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651 [TBL] [Abstract][Full Text] [Related]
16. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy. Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072 [TBL] [Abstract][Full Text] [Related]
17. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723 [TBL] [Abstract][Full Text] [Related]
18. Phototoxicity in near-infrared photoimmunotherapy is influenced by the subcellular localization of antibody-IR700. Nakajima K; Ogawa M Photodiagnosis Photodyn Ther; 2020 Sep; 31():101926. PubMed ID: 32717450 [TBL] [Abstract][Full Text] [Related]
19. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes. Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417 [TBL] [Abstract][Full Text] [Related]